Deze bijdrage is niet beschikbaar.
Nu lid worden Aanmelden
Meer relevante bijdragen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
What an amazing week full of great conversations, scientific exchange, and inspiration at the Tucson Symposium 2024, together with Thierry P.P. van den Bosch, PhD en Mark Steenbergen.We learned about novel therapeutic strategies for patients and the role of omics biomarkers in patient management. The relevance of (multi-cancer) early detection and screening, all while never losing sight of prevention. Many groundbreaking technologies have been shared, from multiplexing and novel virtual staining to rapid detection of genomic alterations from H&E and generative AI analysis. I'm feeling fortunate to live in a country with access to these novel innovations. I was truly impressed by dr. Emmanuella Amoako, who shared with us the unmet needs of cancer care in Africa and highlighted how diversity and inclusivity contributes to precision medicine for all of us. We were reminded that, in the value of diagnostics lies the value of life; for the patient, the family and their community.As the symposium wrapped up, one thing's clear: we're not done, not yet. #tucsonsymposium2024 #rochediagnostics
130
1 commentaar
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
Zie ik je vandaag beurs?
5
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
WOW. Reflecting on TOMORROWLAB fills us with pride 🚀I had the incredible opportunity to present at TOMORROWLAB, an event for our customers that felt like a journey into the future of diagnostics. Bart van den Bogaard and I were excited to share our insights about the value medical algorithms bring to clinical practice. It was an honor to share the stage that day with so many incredible speakers; Robert de Jonge, Ian Parfrement, and Rafael Jacom shared their vision on the transformation of diagnostics, the value of diagnostics to deliver the right care, and the integration of different disciplines in the lab. TOMORROWLAB wasn't just about looking ahead – it was also about honoring our past and reflecting on the current challenges we see today. It was clear that collaboration, digitalization and data exchange were key to optimize network care, and to ultimately deliver the best care for patients. Thanks to the organizing team, all speakers, and of course everybody present for making this event a great success. Mark Fellmann, Joanne Bradley, Frank Mallens, Barbara Kamp, Julia D., Hülya Roggeveen Susana Gomes Eleni Menegatou Ruben Le Noble and many more! #ToekomstVanDiagnostiek #RocheDiagnostics #IntegratedDiagnostics
114
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
Cancer care should not be determined by who you are or where you live. Early detection and accurate diagnosis are pivotal in ensuring appropriate cancer care and improve patients outcomes. Yet for many patients across the world, cancer is diagnosed at a late stage, making it more difficult to treat. This #WorldCancerDay Roche is standing with the @uicc_official in calling for better collaboration among all stakeholders to finally #CloseTheCareGap across the entire cancer care journey.Read more about how we work to make sustainable changes toward closing the Cancer Care Gap.https://lnkd.in/eHBHAqrA
31
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
Zie ik je a.s. woensdag? Registreren kan via: https://lnkd.in/eKkvrbRZMet dank aan programma commissie en de sprekers: lizza hendriks Jan von der ThĂĽsen LĂ©on van Kempen Carla Van Herpen @Daan van den Broek @Willemijn Theelen Kim Monkhorst Wendy de Leng @Carolien van Deurzen Niven Mehra
12
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten heeft dit gerepost
- Deze bijdrage melden
27
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
Morgen sta ik op de Zorg & ICT beurs! Benieuwd naar de laatste digitale ontwikkelingen op het gebied van diagnostiek? Ik zie je graag bij stand 01.B119.
8
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
In today’s tech-enabled, ever-connected world, healthcare providers increasingly use digital medical algorithms to help determine the best course of action in patient care. For the promise of medical algorithms to be fulfilled, they need to be implemented effectively. Read and learn how digital medical algorithms can enhance clinical decision making and contribute towards optimized patient care. #digital #algorithms #healthcare
29
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
Op woensdag 2 november organiseren we voor de zesde keer het Oncologie Update Symposium:“Predictieve diagnostiek voor immuun- en doelgerichte therapie”. Met dank aan de programma commissie en de sprekers: lizza hendriks Jan von der Thüsen Léon van Kempen Carla Van Herpen John Martens Niven Mehra Yes Van De WouwHopelijk zie ik je fysiek @ Green Village of virtueel!Inschrijven kan via:https://lnkd.in/eWHqWCPZ
19
1 commentaar
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
-
Evy Verstraaten
Medical Value Partner - Oncology at Roche Diagnostics Nederland
- Deze bijdrage melden
Very excited to share this recent multidisciplinaryexpert paper highlighting practical recommendations on the use of liquid biopsyin NSCLC, including clinical scenarios where ctDNA testing could have a complementaryvalue.#liquidbiopsy #nsclc #ctdna
10
Interessant CommentaarMeld u aan als u commentaar wilt bekijken of toevoegen
907 volgers
- 27 bijdragen
Profiel weergeven
Volgen